MICIN

What MICIN does

MICIN is a Japanese digital health company founded in November 2015 by Seigo Hara, a physician with a Stanford MBA and prior McKinsey experience. The company operates four business segments: (1) a Medical Experience business built around the curon platform, which provides online medical consultations, pharmacy dispensing guidance, and cashless clinic-visit payments; (2) a Clinical Development Digital Solutions business under the MiROHA brand, offering decentralized clinical trial infrastructure including eConsent, eSource, and telemedicine for trial visits; (3) a Digital Therapeutics business anchored by MedBridge, an IBS treatment app in development, and obesity-focused consultation services; and (4) an Insurance business operated through a wholly-owned subsidiary (MICIN Small-Amount Short-Term Insurance) offering micro short-term health products. The company serves medical institutions, pharmacies, individual patients, pharmaceutical companies running clinical trials, and insurance partners, with operations concentrated in Japan's Kanto region.

MICIN's technology stack is anchored by the curon online consultation platform launched in April 2016, which enables end-to-end virtual visits covering reservation, intake, consultation, payment, and prescription delivery, along with curon SmartPass for in-clinic cashless payment with an optional Fast Pass priority service at 500 JPY per use. The MiROHA suite digitizes clinical trial workflows, having been deployed for Japan's first fully remote injectable oncology trial in April 2025 in collaboration with Aichi Cancer Center and St. Marianna University Hospital. The company has published research on large language model performance on Japan's national medical licensing exam with Kanazawa University and operates the high-precision AI-OCR 'Yakushimaru Kenta' for pharmacy dispensing workflows.

The business model is predominantly freemium and product-led for medical institutions (zero initial and monthly fees), with monetization through transaction volumes, premium features (Fast Pass), enterprise contracts with pharmaceutical companies for clinical trial solutions, and insurance premiums through its wholly-owned insurance subsidiary. Nippon Life Insurance adopted the curon service in March 2025 as a bundled benefit in a new medical insurance product, providing three free annual uses per policyholder. The company has raised approximately $37 million across disclosed funding rounds, most recently a $26.8 million Series C in October 2023 led by World Innovation Lab, with prior backing from Mitsubishi Corporation and strategic investors including multiple Japanese life insurers.

Name

MICIN

Legal name

株式会社MICIN

Website

https://micin.jp

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

51–100 employees

Short description

MICIN is a Japanese digital health company operating the curon online medical consultation platform, MiROHA decentralized clinical trial solutions, MedBridge digital therapeutics, and a micro short-term insurance subsidiary, serving clinics, pharmacies, pharmaceutical companies, and patients primarily in Japan's Kanto region.

Ownership category

akta.pro rank

Product category

Digital Health Platform

akta.pro primary industry

Prescription-Based Digital Clinics (Condition-Specific Rx Programs) (HLALAAAD)

akta.pro secondary industries

Primary Care & General Medicine Virtual Care (HLALAAAA), Virtual Visit & Scheduling Platforms (EHR-integrated) (HLALABAA)

Keywords

• Online medical consultations
• Clinical trial digitization
• Digital therapeutics
• Healthcare IT platform
• Telemedicine services

Headquarters

HQ city

Otemachi

HQ country

Japan

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Online Medical Consultation (curon): Subscription/transaction fees from online consultation services provided to medical institutions and patients. The platform is free for medical institutions to introduce and use (zero initial and monthly costs), with revenue derived from transaction volume and potentially premium service fees such as the Fast Pass feature (500 JPY per use).
2. MiROHA Clinical Development Digital Solutions: Providing digital solutions (online consultation, eConsent, eSource) to pharmaceutical companies and medical institutions conducting clinical trials. Revenue is generated through service contracts with pharmaceutical companies and hospitals.
3. Digital Therapeutics (MedBridge): Digital therapeutic applications providing medically evidence-based software interventions for disease management, prevention, and treatment support.
4. MICIN Insurance (Insurance Business): Microscale short-term insurance business providing insurance products linked to medical services, allowing subscribers to receive insurance payouts for medical expenses.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

MICIN develops and operates digital health platforms connecting patients with healthcare providers and enabling clinical trials. Its core product curon is a freemium online medical consultation platform launched in 2016 that allows patients to complete appointment booking, consultation, examination, payment, and prescription delivery via smartphone. The company also offers MiROHA clinical trial digitization (eConsent/eSource), MedBridge digital therapeutics, and a micro short-term insurance subsidiary.

Product overview

MICIN operates as a digital health platform company organized into four business segments: (1) Medical Experience Business (IT Product Business) offering the クロン (Curon) suite of online medical services including クロンオンライン診療 (online consultations), クロンお薬サポート (pharmacy support), and クロンスマートパス (cashless clinic payments); (2) Clinical Development Digital Solutions (MiROHA) providing decentralized clinical trial infrastructure including online consultations, eConsent, and eSource modules; (3) Digital Therapeutics (MedBridge) for evidence-based software interventions supporting disease management and self-care; and (4) Insurance Business through MICIN少額短期保険 for healthcare-related insurance products. The クロン suite serves as the primary consumer-facing platform, while MiROHA targets clinical trial sponsors and sites, and MedBridge supports patient therapeutic interventions.

Differentiator

Problem solved

Functional benefit

Brands

• クロン (curon): Online medical consultation platform connecting patients with doctors via smartphone or computer, covering appointments, medical interviews, consultations, payments, and medicine delivery. Launched in April 2016.
• クロンお薬サポート
• クロンスマートパス (curon SmartPass)
• MiROHA (ミロハ)
• MedBridge (メドブリッジ)
• MICIN少額短期保険
• Digital Health Times

Products and services

• curon Online Medical Consultations (クロンオンライン診療) Online medical consultation service launched in April 2016, enabling patients to conduct the full medical visit (appointment booking, intake questionnaire, consultation, payment, and prescription delivery arrangements) via smartphone, computer, or tablet. Physicians can also conduct consultations using standard devices with zero initial or monthly fees.
• curon Pharmacy Support (クロンお薬サポート) Pharmacy-specific online medication guidance service enabling pharmacy pharmacists to conduct telephone or video consultations with patients at home. Features include credit card payment processing and prescription delivery coordination.
• curon SmartPass (クロンスマートパス) Cashless payment and clinic visit experience service for in-person consultations. Patients can complete check-in, automatic payment settlement, and prescription pickup notification via smartphone. Includes an optional Fast Pass priority consultation feature at 500 JPY per use.
• MiROHA Clinical Development Digital Solutions (ミロハ) Clinical development digital solutions platform enabling decentralized clinical trials. Includes MiROHA Online Consultations (telehealth replacing in-person trial visits), MiROHA eConsent (electronic informed consent), and MiROHA eSource (digital clinical trial data capture). Sold to pharmaceutical companies conducting clinical trials.
• MedBridge Digital Therapeutics (メドブリッジ) Digital therapeutic system supporting patient self-care habit formation. Collects patient-reported subjective and objective health data, providing physicians and nurses with accessible information during consultations. Includes an IBS treatment mobile application co-developed in 2025.
• MICIN Small-Amount Short-Term Insurance (MICIN少額短期保険) Insurance subsidiary providing medical and healthcare-related insurance products distributed by MICIN Small-Amount Short-Term Insurance Inc., leveraging technology to offer insurance aligned with evolving healthcare needs.

Quantifiable outcome

• Fast Pass users completed clinic visit in under 30 minutes vs. approximately 1 hour for regular patients (based on internal comparison report)

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature5 records

Partnerships

Ten partnerships are on record, tiered minor and core.

• くすりの福太郎minorChannel Partner/ Reseller/ Distributor · 22 June 2025くすりの福太郎 (Kusurin no Fukutarou) pharmacy chain implemented MICIN's pharmacy online dispensing guidance service クロンお薬サポート combined with high-precision AI-OCR '薬師丸賢太', in the Tokyo metropolitan area, enabling telephone and video-based dispensing guidance with payment and delivery coordination.
• 愛知県がんセンター / 聖マリアンナ医科大学病院coreStrategic or Co-development Partner · 24 April 2025Aichi Cancer Center, St. Mary's University Hospital, and MICIN implemented Japan's first fully remote online clinical trial for injectable investigational drugs in the oncology field, utilizing MiROHA's online consultation capabilities.
• 日本デジタルヘルス・アライアンス (Japan Digital Health Alliance)coreStrategic or Co-development Partner · 7 February 2025MICIN participates in the Japan Digital Health Alliance, which published Version 2.0 of a Generative AI utilization guide for healthcare businesses. This alliance brings together leading healthcare and technology players to advance digital health standards in Japan.
• インパクトスタートアップ協会 (Impact Startup Association)minorOthers · 16 January 2025MICIN became a full member of the Impact Startup Association, supporting its mission to promote impact-driven startups that address social and environmental challenges through innovative business models.
• アムジェン (Amgen)coreStrategic or Co-development Partner · 9 December 2024Amgen, MICIN, and Shizuoka Cancer Center began using MiROHA eConsent for cancer corporate clinical trials, aiming to promote decentralized clinical trials (DCT) in the oncology field. This partnership enables remote, patient-friendly clinical trial participation.
• 聖マリアンナ医科大学病院 ( Lung Cancer Clinical Trial)coreStrategic or Co-development Partner · 11 November 2024MICIN began providing MiROHA at St. Mary's University Hospital for a lung cancer corporate-led clinical trial, extending the use of MiROHA's digital clinical trial solutions to the oncology field.
• 東北大学 (Tohoku University)minorStrategic or Co-development PartnerTohoku University is involved in collaborative wearable research projects in Japan, alongside other major players including Daiichi Sankyo, Takeda Pharmaceutical, and MICIN, as part of a broader digital health ecosystem initiative.
• 第一三共 (Daiichi Sankyo)minorStrategic or Co-development PartnerDaiichi Sankyo participates in collaborative wearable research projects in Japan involving Tohoku University, Takeda Pharmaceutical, and MICIN, as part of digital health ecosystem development.
• 武田製薬工業 (Takeda Pharmaceutical)minorStrategic or Co-development PartnerTakeda Pharmaceutical is involved in collaborative wearable research projects in Japan alongside Tohoku University, Daiichi Sankyo, and MICIN, contributing to the advancement of digital health solutions in Japan.
• 山下医院 / Inaba ClinicminorChannel Partner/ Reseller/ DistributorInaba Clinic in Shibuya is an early adopter of クロンスマートパス with the Fast Pass feature, providing feedback and serving as a reference customer for the service.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Medley Inc. Japanese healthcare cloud and telemedicine company operating CLINICS online consultation platform. Directly comparable to MICIN's curon for online medical consultation serving clinics, hospitals, and patients in Japan with similar freemium B2B2C model.
• LINE Healthcare: LINE-affiliated Japanese online medical consultation service. Direct competitor to MICIN's curon in the Japanese DTC virtual primary care space, leveraging LINE's consumer messaging reach for patient acquisition.
• Doctor Wallet Inc. Japanese online medical consultation and clinic SaaS provider. Closely comparable to MICIN's curon and SmartPass products for clinic-side digital workflows and patient-facing telehealth.
• CureApp: Japanese digital therapeutics company developing FDA- and PMDA-cleared therapeutic apps. Closely comparable to MICIN's MedBridge business and new IBS treatment app co-development, sharing the Japan-anchored DTx regulatory pathway.

Broad incumbents

• M3 Inc. Major Japanese digital health and physician network platform with m3.com portal and online consultation services. Overlaps with MICIN on telehealth and clinical trial solutions but operates at significantly larger scale across multiple healthcare verticals.
• Veeva Systems: Global cloud platform for life sciences with clinical trial and eConsent/eSource capabilities. Comparable to MICIN's MiROHA platform for DCT digitization, though Veeva operates globally at much larger scale and across a broader pharma stack.
• Medidata Solutions (Dassault Systèmes): Global clinical trial technology provider with eCOA, eConsent, and DCT infrastructure. Direct functional comparator to MICIN's MiROHA eConsent and eSource for decentralized clinical trials serving pharma sponsors.

Emerging players

• Ubie Inc. Tokyo-based AI healthcare platform providing symptom checking and digital patient intake tools. Compares to MICIN's clinical workflow digitization efforts (patient charts, intake) and shares the Japanese digital health focus, though with an AI-triage angle.
• Doctolib: European leader in online medical consultation and practice management software. Comparable to MICIN's integrated curon + SmartPass approach combining patient-facing telehealth with clinic-side workflow tools, though operating in different geographies.

Regional players

• Smart119: Japanese emergency and telehealth platform with strong Chiba University hospital backing. Compares to MICIN on the telemedicine infrastructure layer but focuses more on emergency and EMS use cases within Japan.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/micin_inc

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries1 record

Funding overview

Funding rounds4 records

Investors12 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MICIN